CANTAB

CANTAB

CANTAB

The most validated cognitive research software

CANTAB neuropsychological tests

Cognitive assessments are invaluable tools for understanding the role of specific brain functions across a range of disorders and syndromes; giving insight into underlying causes, identifying ways to detect the earliest symptoms and evaluating the effects of interventions designed to improve brain health.

Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test Automated Battery (CANTAB) includes highly sensitive, precise and objective measures of cognitive function, correlated to neural networks.

CANTAB tests have demonstrated sensitivity to detecting changes in neuropsychological performance1 and include tests of working memory, learning and executive function; visual, verbal and episodic memory; attention, information processing and reaction time; social and emotion recognition, decision making and response control.2,3,4,5,6
 

CANTAB cognitive tests are:

Suitable for all areas of research, especially CNS, neurological & psychiatric research

Validated by 30 years of global neuroscience research

Published in over 2,000 peer-reviewed papers and cited over 100,000 times

Used extensively in global pharmaceutical trials, academic research & healthcare

Recognised by regulatory bodies as a clinical outcome measure

The tests show high sensitivity to positive and negative pharmacological, genetic and environmental effects in healthy individuals and patient populations across all areas of research. CANTAB is language-independent, culturally neutral, non-invasive and require no technical knowledge or prior familiarity with computers making them suitable for large, multi-site studies and diverse participant groups7,8.

Why choose CANTAB?
Discover what makes CANTAB the gold standard in digital cognitive assessment and data collection

 


References

  1. Sahakian, Barbara J.; Morris, Robin G.; Evenden, John L.; Heald, Andrew; Levy, Raymond; Philpot, Michael; Robbins, Trevor W. (1988). "A Comparative Study of Visuospatial Memory and Learning in Alzheimer-Type Dementia and Parkinson's Disease". Brain 111 (3): 695–718. doi:10.1093/brain/111.3.695. PMID 3382917.
  2. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW (1988). Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry. Jun;51(6):757-66.
  3. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989). Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia. 1989;27(11-12):1329-43.
  4. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990). Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia. 28(10):1021-34.
  5. Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BJ, Blackwell AD, Barnett JH (2011). Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry. Jun 15;69(12):1192-203.
  6. Kehagia AA, Murray GK, Robbins TW (2010). Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol. Apr;20(2):199-204.
  7. Luciana M, Nelson C (2002). "Assessment of Neuropsychological Function Through Use of the Cambridge Neuropsychological Testing Automated Battery: Performance in 4- to 12-Year-Old Children". Developmental Neuropsychology 22 (3): 595–624.
  8. Robbins, TW; James, M; Owen, AM; Sahakian, BJ; McInnes, L; Rabbitt, P (1994). "Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers". Dementia 5 (5): 266–81. doi:10.1159/000106735.PMID 7951684